The DOI matches its Crossref record.
Excerpts From the US Renal Data System 2009 Annual Data Report
Open accessOverview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cited by
Sorted by citations
Astor, B. C., Matsushita, K., Gansevoort, R. T., van der Velde, M., Woodward, M., Levey, A. S., de Jong, P. E., & Coresh, J. (2011) · Kidney International · doi:10.1038/ki.2010.550 · Cited by 775
“In this meta-analysis of 13 cohorts, including 21,688 individuals selected because of CKD, we found that lower eGFR and higher albuminuria were each independently associated with mortality and ESRD.”
BackgroundInfluentialSeferović, P. M., Petrie, M. C., Filippatos, G. S., Anker, S. D., Rosano, G., Bauersachs, J., Paulus, W. J., Komajda, M., Cosentino, F., de Boer, R. A., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1170 · Cited by 708
Lipocalin 2 is essential for chronic kidney disease progression in mice and humans
Viau, A., Karoui, K. E., Laouari, D., Burtin, M., Nguyen, C., Mori, K., Pillebout, É., Berger, T., Mak, T. W., Knebelmann, B., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42004 · Cited by 393
Kidney stones and kidney function loss: a cohort study
Alexander, R. T., Hemmelgarn, B. R., Wiebe, N., Bello, A. K., Morgan, C., Samuel, S. M., Klarenbach, S. W., Curhan, G. C., Tonelli, M. A., & for the Alberta Kidney Disease Network (2012) · BMJ · doi:10.1136/bmj.e5287 · Cited by 354
International Journal of Collaborative Research on Internal Medicine & Public Health
Valdivia, J. R. M. (2021) · Journal of Womens Health Issues and Care · Cited by 300
Timing of nephrologist referral and arteriovenous access use: The CHOICE Study
Astor, B. C., Eustace, J. A., Powe, N. R., et al. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.26833 · Cited by 266
Frequency of and risk factors for poor cognitive performance in hemodialysis patients
Sarnak, M. J., Tighiouart, H., Scott, T. M., Lou, K. V., Sorensen, E. P., Giang, L. M., Drew, D. A., Shaffi, S. K., Strom, J. A., Singh, A. K., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31827f0f7f · Cited by 258
Challenges in the management of the blood supply
Williamson, L. M., & Devine, D. V. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60631-5 · Cited by 240
Outcomes of Arteriovenous Fistula Creation after the Fistula First Initiative
Schinstock, C. A., Albright, R. C., Williams, A. W., Dillon, J. J., Bergstralh, E. J., Jenson, B. M., McCarthy, J. T., & Nath, K. A. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11251210 · Cited by 234
Hsu, T.-W., Liu, J., Hung, S., Kuo, K., Chang, Y., Chen, Y., Hsu, C.-C., & Tarng, D. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12700 · Cited by 219
Self-citationJohnson, L. A., Rodansky, E. S., Haak, A. J., Larsen, S. D., Neubig, R. R., & Higgins, P. (2013) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000437615.98881.31 · Cited by 203
Gembardt, F., Bartaun, C., Jarzebska, N., Mayoux, E., Todorov, V., Hohenstein, B., & Hugo, C. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00145.2014 · Cited by 192
Poverty, Race, and CKD in a Racially and Socioeconomically Diverse Urban Population
Crews, D. C., Charles, R. F., Evans, M. K., Zonderman, A. B., & Powe, N. R. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.12.032 · Cited by 188
Haemodialysis-induced hypoglycaemia and glycaemic disarrays
Abe, M., & Kalantar‐Zadeh, K. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.38 · Cited by 187
Descamps‐Latscha, B., Witko‐Sarsat, V., Nguyen‐Khoa, T., Nguyen, A., Gausson, V., Mothu, N., London, G. M., & Jungers, P. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.09.011 · Cited by 182
Knockdown of Glyoxalase 1 Mimics Diabetic Nephropathy in Nondiabetic Mice
Giacco, F., Du, X., D’Agati, V. D., Milne, R. W., Sui, G., Geoffrion, M., & Brownlee, M. (2013) · Diabetes · doi:10.2337/db13-0316 · Cited by 184
Molecular Mechanisms of Renal Blood Flow Autoregulation
Burke, M. F., Pabbidi, M. R., Farley, J. M., & Roman, R. J. (2014) · Current Vascular Pharmacology · doi:10.2174/15701611113116660149 · Cited by 176
“9 billion in Medicare costs alone) for the treatment of an estimated 500,000 patients in the US [43].”
BackgroundWang, I., Muo, C., Chang, Y.-C., Liang, C., Chang, C., Lin, S., Yen, T., Chuang, F., Chen, P., Huang, C.-C., et al. (2013) · Canadian Medical Association Journal · doi:10.1503/cmaj.120230 · Cited by 169
“Limitations The incidence and prevalence of end-stage renal disease in Taiwan is among the highest in the world.(29) Although we performed a large national cohort study, our study has several limitations.”
BackgroundLow Bone Mineral Density and Fractures in Long-Term Hemodialysis Patients: A Meta-Analysis
Jamal, S. A., Hayden, J. A., & Beyene, J. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.02.264 · Cited by 148
Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children
Rodieux, F., Wilbaux, M., van den Anker, J. N., & Pfister, M. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0298-7 · Cited by 149
Shear wave elastography in chronic kidney disease: a pilot experience in native kidneys
Samir, A. E., Allegretti, A. S., Zhu, Q., Dhyani, M., Anvari, A., Sullivan, D. A., Trottier, C. A., Dougherty, S., Williams, W. W., Babitt, J. L., et al. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0120-7 · Cited by 138
“Projections suggest that the number of patients who will require dialysis or transplantation for kidney failure will rise to over 2 million people by 2030 [3, 4].”
BackgroundVascular Access Choice in Incident Hemodialysis Patients
Drew, D. A., Lok, C. E., Cohen, J. T., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013111236 · Cited by 137
Increased risk of cancer in chronic dialysis patients: a population-based cohort study in Taiwan
Lin, H.-F., Li, Y.-H., Wang, C.-H., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr464 · Cited by 124
“Taiwan has the highest incidence and prevalence of end-stage renal disease (ESRD) in the world [9, 10].”
Self-citationSayyed, S. G., Ryu, M., Kulkarni, O. P., Schmid, H., Lichtnekert, J., Grüner, S., Green, L., Mattei, P., Hartmann, G. R., & Anders, H. (2011) · Kidney International · doi:10.1038/ki.2011.102 · Cited by 121
Duni, Α., Liakopoulos, V., Rapsomanikis, K.-P., & Dounousi, E. C. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9036450 · Cited by 127
“5 years for those 60 to 64 years of age suggesting that survival especially in older patients is comparable only to that of patients with lung cancer [5].”
BackgroundIL-1β Receptor Antagonist Reduces Inflammation in Hemodialysis Patients
Hung, A. M., Ellis, C. D., Shintani, A., Booker, C., & Ikizler, T. A. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010070760 · Cited by 120
Tamura, M. K., Tan, J. C., & O’Hare, A. M. (2011) · Kidney International · doi:10.1038/ki.2011.384 · Cited by 118
“With respect to patient-reported outcomes, changes in quality of life over time are similar among PD vs. HD patients, although PD patients report greater satisfaction with care.15,20 PD patients require fewer access procedures than patients receiving HD with a CVC.21 PD also preserves residual renal function to a grea…”
InfluentialJaar, B. G., Astor, B. C., Berns, J. S., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00420.x · Cited by 115
Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease
O’Seaghdha, C. M., Hwang, S., Muntner, P., Melamed, M. L., & Fox, C. S. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq808 · Cited by 118
Inflammation, wound repair, and fibrosis: reassessing the spectrum of tissue injury and resolution
White, E. S., & Mantovani, A. (2012) · The Journal of Pathology · doi:10.1002/path.4126 · Cited by 111
Zhu, C., Liang, Q., Hu, P., Wang, Y., & Luo, G. (2011) · Talanta · doi:10.1016/j.talanta.2011.05.036 · Cited by 105
Mechanisms and biological functions of autophagy in diseased and ageing kidneys
Fougeray, S., & Pallet, N. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.201 · Cited by 105
Krishnan, S. T., Devadhasan, J. P., & Kim, S. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9903-3 · Cited by 100
Transforming Growth Factor-β, Bioenergetics, and Mitochondria in Renal Disease
Casalena, G., Daehn, I. S., & Böttinger, E. P. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.04.009 · Cited by 101
Vaziri, N. D. (2013) · Clinical and Experimental Nephrology · doi:10.1007/s10157-013-0847-z · Cited by 99
“Patients with CKD exhibit accelerated atherosclerosis and cardiovascular disease which are the primary cause of death in this population [35, 36].”
BackgroundTzur, S., Rosset, S., Skorecki, K. L., & Wasser, W. G. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr796 · Cited by 93
“The 5-year survival of incident dialysis patients is 32%, less than the survival in many forms of cancer [16, 17].”
BackgroundMortazavi, M., Moeinzadeh, F., Saadatnia, M., et al. (2013) · European Neurology · doi:10.1159/000346427 · Cited by 90
Intestinal organoids: A model of intestinal fibrosis for evaluating anti-fibrotic drugs
Rodansky, E. S., Johnson, L. A., Huang, S., Spence, J. R., & Higgins, P. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.03.033 · Cited by 87
Relation between gender and vascular access complications in hemodialysis patients
Astor, B. C., Coresh, J., Powe, N. R., et al. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.19816 · Cited by 88
ADAM17 at the interface between inflammation and autoimmunity
Lisi, S., D’Amore, M., & Sisto, M. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.08.008 · Cited by 88
Cellular Senescence and the Kidney: Potential Therapeutic Targets and Tools
Knoppert, S. N., Valentijn, F. A., Nguyen, T. Q., Goldschmeding, R., & Falke, L. L. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00770 · Cited by 88
Comparative effectiveness of incident oral antidiabetic drugs on kidney function
Hung, A. M., Roumie, C. L., Greevy, R. A., Liu, X., Grijalva, C. G., Murff, H. J., Ikizler, T. A., & Griffin, M. R. (2012) · Kidney International · doi:10.1038/ki.2011.444 · Cited by 83
“In the United States, diabetes accounts for 45% of incident end-stage renal disease (ESRD).(2) In 2006, the US federal government estimated cost was $23 billion for ESRD treatment, and the corresponding CKD treatment cost was $49 billion.”
BackgroundInfluentialRicks, J., Molnar, M. Z., Kovesdy, C. P., Kopple, J. D., Norris, K. C., Mehrotra, R., Nissenson, A. R., Arah, O. A., Greenland, S., & Kalantar‐Zadeh, K. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.03.023 · Cited by 81
Renal Biopsy in Type 2 Diabetic Patients
Espinel, E., Agraz, I., Ibernón, M., Ramos-Terrades, N., Fort, J., & Serón, D. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4050998 · Cited by 81
“Moreover, patient survival in diabetics on maintenance dialysis is lower than in non-diabetic patients with end-stage renal disease due to other renal diseases [6].”
BackgroundHomoarginine, Heart Failure, and Sudden Cardiac Death in Haemodialysis Patients
Drechsler, C., Meinitzer, A., Pilz, S., et al. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr056 · Cited by 77
Liu, Y., Ma, X., Zheng, J., Jia, J., & Yan, T. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0605-7 · Cited by 75
“Background Cardiovascular events (CVEs) are the leading causes of death among dialysis patients, with mortality rates 7 to 30 times higher than in the general population [1, 2].”
BackgroundPatients’ perspectives on dialysis decision-making and end-of-life care
Saeed, F., Sardar, M., Davison, S. N., Murad, H., Duberstein, P. R., & Quill, T. E. (2019) · Clinical Nephrology · doi:10.5414/cn109608 · Cited by 76
Untargeted plasma and tissue metabolomics in rats with chronic kidney disease given AST-120
Velenosi, T. J., Hennop, A., Feere, D. A., Tieu, A., Kucey, A. S., Kyriacou, P., McCuaig, L. E., Nevison, S. E., Kerr, M. A., & Urquhart, B. L. (2016) · Scientific Reports · doi:10.1038/srep22526 · Cited by 72
Smith, J. R., Zimmer, N., Bell, E., Francq, B., McConnachie, A., & MACTIER, R. A. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.10.025 · Cited by 68
Kim, D. H., Kim, M., Kim, H., Kim, Y.-L., Kang, S., Yang, C. W., Kim, N., Kim, Y. S., & Lee, J. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055323 · Cited by 68
“Patients with end-stage renal disease (ESRD) have an exceedingly high morbidity and mortality compared to the general population [1].”
BackgroundLertdumrongluk, P., Rhee, C. M., Park, J., et al. (2013) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2013.01.018 · Cited by 66
“49-52 The mechanisms by which hyperphosphatemia contributes to the initiation and progression of vascular calcification include (1) transformation of vascular smooth muscle cells (VSMCs) from a contractile to an osteochondrogenic phenotype and mineralization of VSMC matrix through sodiumdependent phosphate co-transpor…”
Vitamin E tocotrienol supplementation improves lipid profiles in chronic hemodialysis patients
Khosla, P., Daud, Z. A. M., Tubie, B., Sheyman, M., Osia, R., Adams, J., & Tubie, S. (2013) · Vascular Health and Risk Management · doi:10.2147/vhrm.s51710 · Cited by 66
Sorensen, E. P., Sarnak, M. J., Tighiouart, H., Scott, T. M., Giang, L. M., Kirkpatrick, B., Lou, K. V., & Weiner, D. E. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.12.029 · Cited by 63
“Dialysis duration (mo) 33 (12-48) 29 (15-62) Cause of ESRD (%) Diabetes 33 33 Hypertension 15 25 Glomerulonephritis 8 20 Other 20 10 Unknown 25 13”
Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients
Drechsler, C., Ritz, E., Tomaschitz, A., Pilz, S., Schönfeld, S., Blouin, K., Bidlingmaier, M., Hammer, F., Krane, V., März, W., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs361 · Cited by 62
Plasma contact factors as therapeutic targets
Tillman, B. F., Gruber, A., McCarty, O. J. T., & Gailani, D. (2018) · Blood Reviews · doi:10.1016/j.blre.2018.04.001 · Cited by 65
“Patients with renal failure, regardless of whether or not they have atrial fibrillation, have high rates of cardiovascular events that account for about half of the group mortality [117,191].”
BackgroundKim, J., Park, S., Lee, M. J., Song, Y. R., Han, S. H., Kim, S. G., Kang, S., Choi, K. H., Kim, H. J., & Yoo, T. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.07.115 · Cited by 63
“The mortality rate of end-stage renal disease (ESRD) patients is t least 20–30 times higher than age- and gender-matched healthy ontrols; cardiovascular and cerebrovascular diseases resulting rom an accelerated process of atherosclerosis comprise the two eading causes ofmorbidity andmortality [1].”
BackgroundMolnar, M. Z., Streja, E., Kovesdy, C. P., Budoff, M. J., Nissenson, A. R., Krishnan, M., Anker, S. D., Norris, K. C., Fonarow, G. C., & Kalantar‐Zadeh, K. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.014639 · Cited by 59
“Platelet reactivity plays a central role in the genesis of thrombosis and thromboembolic events, especially in atherosclerotic cardiovascular disease—the leading cause of death in ESRD and CHF patients (3).”
BackgroundResultInfluentialWang, I., Lin, C., Lin, P., Liang, C., Liu, Y., Chang, C., Yen, T., Morisky, D. E., Huang, C.-C., & Sung, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058317 · Cited by 57
“Infection is the second leading cause of mortality and a major cause of morbidity in ESRD patients [5].”
BackgroundCano-Megías, M., Guisado‐Vasco, P., Bouarich, H., et al. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1367-1 · Cited by 56
“Increasing length of time on dialysis is a related to higher mortality rates [19].”
BackgroundXiong, D., Hu, W., Han, X., et al. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2805100 · Cited by 55
Kidney organoids in translational medicine: Disease modeling and regenerative medicine
Miyoshi, T., Hiratsuka, K., Saiz, E. G., & Morizane, R. (2019) · Developmental Dynamics · doi:10.1002/dvdy.22 · Cited by 57
“Thus, loss of nephrons is permanent and ultimately leads to endstage kidney disease (ESKD), where patients require renal replacement therapies, such as hemodialysis, associated with high mortality and morbidity.(58) In addition, there are limited human disease models for the development of treatment methods and identi…”
BackgroundCognitive Function and Dialysis Adequacy: No Clear Relationship
Giang, L. M., Weiner, D. E., Agganis, B. T., Scott, T. M., Sorensen, E. P., Tighiouart, H., & Sarnak, M. J. (2010) · American Journal of Nephrology · doi:10.1159/000322611 · Cited by 56
Salmhofer, H., Franzen, M., Hitzl, W., et al. (2013) · Kidney & Blood Pressure Research · doi:10.1159/000350162 · Cited by 52
Chronic Kidney Disease in the Elderly
Maw, T. T., & Fried, L. F. (2013) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2013.05.003 · Cited by 67
State Medicaid Coverage, ESRD Incidence, and Access to Care
Tamura, M. K., Goldstein, B. A., Hall, Y. N., Mitani, A., & Winkelmayer, W. C. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013060658 · Cited by 51
Drug-induced Kidney Disease – Pathology and Current Concepts
Loh, A. H. L., & Cohen, A. H. (2009) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v38n3p240 · Cited by 51
Eneanya, N. D., Goff, S. L., Martinez, T., Gutierrez, N., Klingensmith, J., Griffith, J. L., Garvey, C., Kitsen, J., Germain, M. J., Marr, L., et al. (2015) · BMC Palliative Care · doi:10.1186/s12904-015-0027-x · Cited by 49
“Background More than 600,000 patients in the United States have end-stage renal disease (ESRD), with approximately 450,000 patients undergoing hemodialysis (HD) [1].”
BackgroundInfluentialHSP27 and HSP70 serum and urine levels in patients suffering from chronic kidney disease
Lebherz-Eichinger, D., Ankersmit, H. J., Hacker, S., Hetz, H., Kimberger, O., Schmidt, E. M., Reiter, T., Hörl, W. H., Haas, M., Krenn, C. G., et al. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.10.010 · Cited by 49
Effectiveness of Herpes Zoster Vaccine in Patients 60 Years and Older With End-stage Renal Disease
Tseng, H. F., Luo, Y., Shi, J. M., Sy, L. S., Tartof, S. Y., Sim, J. J., Hechter, R. C., & Jacobsen, S. J. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ930 · Cited by 49
“Infection is the second leading cause of mortality and a major cause of morbidity in ESRD patients [3].”
BackgroundLiang, M., Woodard, L. E., Liang, A., Luo, J., Wilson, M. H., Mitch, W. E., & Cheng, J. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.01.027 · Cited by 48
Clinical outcomes and quality of life in hemodialysis diabetic patients versus non-diabetics
Soleymanian, T., Kokabeh, Z., Ramaghi, R., et al. (2016) · Journal of Nephropathology · doi:10.15171/jnp.2017.14 · Cited by 48
“Diabetes is the most common cause of end stage renal disease (ESRD) in the United States and most other developed and emerging countries (1).”
BackgroundInfluentialβ-Blocker Dialyzability in Maintenance Hemodialysis Patients
Tieu, A., Velenosi, T. J., Kucey, A. S., Weir, M. A., & Urquhart, B. L. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07470717 · Cited by 48
A Review of Cannabis in Chronic Kidney Disease Symptom Management
Ho, C., Martinusen, D. J., & Lo, C. (2019) · Canadian Journal of Kidney Health and Disease · doi:10.1177/2054358119828391 · Cited by 51
Xu, Y., Fu, E. L., Clase, C. M., Mazhar, F., Jardine, M., & Carrero, J. J. (2021) · Kidney International · doi:10.1016/j.kint.2021.10.033 · Cited by 50
Concise Review: Kidney Generation with Human Pluripotent Stem Cells
Morizane, R., Miyoshi, T., & Bonventre, J. V. (2017) · Stem Cells · doi:10.1002/stem.2699 · Cited by 47
Chapdelaine, I., Mostovaya, I. M., Blankestijn, P. J., et al. (2014) · Blood Purification · doi:10.1159/000362108 · Cited by 46
Safety analysis of primary bariatric surgery in patients on chronic dialysis
Andalib, A., Aminian, A., Khorgami, Z., Navaneethan, S. D., Schauer, P. R., & Brethauer, S. A. (2015) · Surgical Endoscopy · doi:10.1007/s00464-015-4530-1 · Cited by 47
“Cardiovascular disease accounts for 50 % of deaths in patients with ESRD with near 20 % attributed to CAD [24].”
BackgroundDai, L., Chen, Y., Sun, W. J., & Liu, S. (2018) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2018.01.022 · Cited by 45
Meeting the challenges of the new K/DOQI guidelines
Eknoyan, G. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00371-8 · Cited by 44
Little, M. A., & Walshe, J. J. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.29885 · Cited by 44
Krisanapan, P., Suppadungsuk, S., Sanpawithayakul, K., Thongprayoon, C., Pattharanitima, P., Tangpanithandee, S., Mao, M. A., Miao, J., & Cheungpasitporn, W. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae018 · Cited by 47
“The increased CV risk associated with DM has been demonstrated to not only affect ESKD patients, but also lead to increased mortality rates across the general population [5 , 8 –10 ].”
BackgroundBuiten, M. S., de Bie, M. K., Rotmans, J. I., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134245 · Cited by 43
Mirmohammadlu, M., Hosseini, S. H., Kamalinejad, M., et al. (2015) · PubMed · Cited by 43
Porter, A. C., Fischer, M. J., Brooks, D. H., et al. (2011) · Translational research · doi:10.1016/j.trsl.2011.09.004 · Cited by 43
Self-citationPerna, A. F., Sepe, I., Lanza, D., et al. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24495 · Cited by 43
Fung, C., Wan, E., Chan, A. K. L., & Lam, C. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0468-y · Cited by 43
Santos, P. W., He, J., Tuffaha, A. M., et al. (2017) · International Urology and Nephrology · doi:10.1007/s11255-017-1721-9 · Cited by 41
“CVD is associated with high morbidity and mortality in dialysis patients [24], yet there are key phenotypic differences that exist between CVD in patients with CKD compared to the general population [25] which may explain our findings.”
BackgroundCardiac imaging for the assessment of patients being evaluated for kidney or liver transplantation
Parikh, K., Appis, A., & Doukky, R. (2014) · Journal of Nuclear Cardiology · doi:10.1007/s12350-014-9997-y · Cited by 41
Bacteremia in Hemodialysis and Peritoneal Dialysis Patients
Wang, I., Chang, Y.-C., Liang, C., et al. (2012) · Internal Medicine · doi:10.2169/internalmedicine.51.7111 · Cited by 40
“A review of the US Renal Data System (USRDS) indicated that first year hospital admission rates for bacteremia were higher for hemodialysis (HD) patients than for peritoneal dialysis (PD) patients (1, 6).”
BackgroundInfluentialBeaubien‐Souligny, W., Kontar, L., Blum, D., Bouchard, J., Denault, A. Y., & Wald, R. (2019) · Kidney International Reports · doi:10.1016/j.ekir.2019.07.003 · Cited by 37
“D espite considerable technological advances over the past 30 years, mortality among maintenance dialysis recipients remains unacceptably high.(1) Although partially attributable to classic cardiovascular risk factors that are commonly found in patients with chronic kidney disease, “nontraditional” risk factors unique…”
BackgroundGwon, M., An, H., Kim, J., Kim, W., Gu, H., Kim, H., Leem, J., Jung, H. J., & Park, K. (2019) · The FASEB Journal · doi:10.1096/fj.201901307rr · Cited by 40
End-Stage Kidney Disease After Pediatric Nonrenal Solid Organ Transplantation
Ruebner, R. L., Reese, P. P., Denburg, M., Abt, P. L., & Furth, S. L. (2013) · PEDIATRICS · doi:10.1542/peds.2013-0904 · Cited by 38
“73 m(2), n (%) $90 8069 (49) 5358 (60) 1617 (29) 586 (61) 444 (46) 64 (41) 60–89 3923 (24) 1848 (21) 1600 (29) 158 (16) 283 (30) 34 (22) 30–59 1783 (11) 752 (8) 877 (16) 41 (4) 103 (11) 10 (6) ,30 or acute dialysis 778 (5) 355 (4) 368 (7) 18 (2) 33 (3) 4 (3) Missing 2051 (12) 645 (7) 1107 (20) 160 (17) 94 (10) 45 (29)”
Impact of age on survival predictability of bone turnover markers in hemodialysis patients
Lertdumrongluk, P., Lau, W. L., Park, J., et al. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft290 · Cited by 38
“Cardiovascular disease is the leading cause of mortality in dialysis patients [1].”
BackgroundIimori, S., Noda, Y., Okado, T., Naito, S., Toda, T., Chida, Y., Kuwahara, M., Ando, R., Nishio, Y., Maeda, Y., et al. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-152 · Cited by 37
“CVD risk factors, such as hypertension, diabetes and dyslipidemia, tend to be highly prevalent and poorly controlled in patients with CKD [8].”
Hemodialysis in children with end-stage renal disease
Müller, D. N., & Goldstein, S. L. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.124 · Cited by 36
Park, J. Y., Kim, M., Han, S. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127240 · Cited by 36
Risk Factors for End-Stage Kidney Disease After Pediatric Liver Transplantation
Ruebner, R. L., Reese, P. P., Denburg, M., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04270.x · Cited by 36
“Living donor, n(%) 1210 (14) Location at time of liver transplant, n(%) Hospitalized, intensive care unit 2427 (27) Hospitalized, non-intensive care unit 1637 (18) Not hospitalized 4905 (55) Immunosuppressive therapy at time of transplant, n(%) Cyclosporine-based 2353 (26) Tacrolimus-based 5724 (64) Other 209 (2) Miss…”
BackgroundHarduin, L. D. O., Barroso, T. A., Guerra, J. B., Filippo, M. G., de Almeida, L. C., de Castro-Santos, G., Oliveira, F. A. C., Cavalcanti, D. E. T., Procópio, R. J., Lima, E. C., et al. (2023) · Jornal Vascular Brasileiro · doi:10.1590/1677-5449.202300522 · Cited by 35
Kjærgaard, K. D., Peters, C. D., Jespersen, B., et al. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.05.011 · Cited by 35
“78 0 [0-15]”
Feyssa, E. L., Jones-Burton, C., Ellison, G. L., et al. (2009) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30822-1 · Cited by 35
Metadata
- Authors
- Collins, A. J., Foley, R. N., Herzog, C., Chavers, B. M., Gilbertson, D., Ishani, A., Kasiske, B. L., Liu, J., Mau, L.-W., McBean, M., Murray, A., St. Peter, W., Guo, H., Li, Q., Li, S., Li, S., Peng, Y., Qiu, Y., Roberts, T., Skeans, M., Snyder, J., Solid, C., Wang, C., Weinhandl, E., Zaun, D., Arko, C., Chen, S.-C., Dalleska, F., Daniels, F., Dunning, S., Ebben, J., Frazier, E., Hanzlik, C., Johnson, R., Sheets, D., Wang, X., Forrest, B., Constantini, E., Everson, S., Eggers, P. W., & Agodoa, L.
- Affiliations
- United States Department of Veterans Affairs (US)
- ORCID
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 55
- Issue
- 1
- Pages
- A6-A7
- ISSN
- 0272-6386 (ISSN-L)
- PMC
- PMC2829836
- OpenAlex
- W1955298113
- Cited by
- 436
- References
- 0
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 12 · 2023: 18 · 2022: 19 · 2021: 22 · 2020: 20 · 2019: 23 · 2018: 35 · 2017: 25 · 2016: 34 · 2015: 40 · 2014: 29 · 2013: 42 · 2012: 37
- FWCI
- 19.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- American Journal of Kidney Diseases (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (HHSN 267 2007 15002C/N01-DK-7-5002, HHSN267200715002C)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- chronic kidney disease, end-stage renal disease, acute kidney injury, mortality risk, blood pressure control, lipid control, health care costs, morbidity, NHANES
- MeSH terms
- Chronic Disease, Medicare, Renal Dialysis, Humans, Kidney Diseases, United States, Kidney Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
